Skip to content
Skip to navigation menu

The Institute's research teams focus on addressing overlapping issues in cardiorespiratory, metabolic and inflammatory disorders by means of state-of-the-art translational medicine studies underpinned by excellent basic science.

  • Oil red O stained adipocytes differentiated from bone marrow stem cells.
  • Dendritic cells shown in red in human epidermis
  • 3D electroanatomic map of an infarcted heart left ventricle
  • Scanning electron microscopy image of endothelial cells shedding microparticles


  • Sudden cardiac death calcium link August 2014Cardiff University scientists identify a mutation in the calcium-sensing protein, calmodulin, that causes idiopathic ventricular fibrillation, has defective interaction with the cardiac ryanodine receptor.
  • Story of TINN2 (treat infections in neonates 2) 23rd June 2014Horizon 2020 reports the story of TINN2, a large-scale study to test the efficacy and safety of the drug called Azithromycin (AZM) with pre-term babies. It is the first such large-scale study in the world.


See also


IMEM undertakes undergraduate teaching and offers well established postgraduate courses:

Postgraduate Research

Clinical Departments

IMEM hosts the academic clinical Departments of Cardiology, Diabetes and Endocrinology, Nephrology , Pharmacology , Child Health and Medical Biochemistry who have responsibility for teaching and supporting clinical services in their specialist areas.

Clinical Trials

IMEM conducts a large number of clinical trials focussing on translation of scientific knowledge to clinical care. These include first-in-man phase 1 and phase 2 'proof of concept' studies.